Skip to content
10-Q

Quarterly Report

EMMAUS LIFE SCIENCES, INC.

0001564590-18-013611

← back to feed
Filed
May 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 11, 2018 34.92M sh
Cash And Equivalents Q1 2018 · Mar 31, 2018 $5.11M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $15.84M
Stockholders Equity Q1 2018 · Mar 31, 2018 $11.52M
Stockholders Equity Q1 2018 · Dec 31, 2017 $14.29M
Current Liabilities Q1 2018 · Mar 31, 2018 $41.08M
Current Liabilities Q1 2018 · Dec 31, 2017 $49.44M
Total Liabilities Q1 2018 · Mar 31, 2018 $101.99M
Total Liabilities Q1 2018 · Dec 31, 2017 $109.55M
Current Assets Q1 2018 · Mar 31, 2018 $112.57M
Current Assets Q1 2018 · Dec 31, 2017 $123.5M
Total Assets Q1 2018 · Mar 31, 2018 $113.5M
Total Assets Q1 2018 · Dec 31, 2017 $123.85M
Capex Q1 2018 · Mar 31, 2017 $40.42K
Eps Basic Q1 2018 · Mar 31, 2017 −$0.19
Sga Expense Q1 2018 · Mar 31, 2017 $2.8M
Rd Expense Q1 2018 · Mar 31, 2017 $755.73K
Net Income Q1 2018 · Mar 31, 2017 −$6.49M
Operating Income Q1 2018 · Mar 31, 2017 −$3.6M
Gross Profit Q1 2018 · Mar 31, 2017 $59.22K
Cost Of Revenue Q1 2018 · Mar 31, 2017 $48.26K